|By Marketwired .||
|May 23, 2014 01:15 PM EDT||
DAYTONA BEACH, FL -- (Marketwired) -- 05/23/14 -- Quture International, Inc. (OTCQB: QUTR) ("Q") the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability, today announced successful completion of its Go to Market Plan for its QualOptima Versions 1 and 2 technology for installations and sales to existing and new customers. Q's extensive development of the QualOptima Connectivity & Analytics System for customer segments and value propositions, including embedded intellectual property, has resulted in potential sale of the full transformational software system for healthcare enterprise management in Version 2.0 at intended reference sites. The Marketing Plan for Version 2.0 focuses on the Clinical Trial at the University of Miami/Jackson Memorial Hospital. Initial marketing, sales and installations in process are for the previously announced Professional Practice Evaluation Application in Version 1 of QualOptima. Marketing and commercial sales are focused on five (5) versions of QualOptima, for software as a service (SaaS) or bundled with consulting through Q's subsidiary QualVal Solutions, LLC, to penetrate the estimated $2.5 billion market in the United States with intentions to expand globally through Q's subsidiary Quture Euro, LLC.
In collaboration with InterSystems Corporation (www.InterSystems.com), Q is expanding its application of InterSystems' tools Cache, Ensemble, DeepSee and iKnow and information technology (IT) staffing with addition of a Chief Software Architect and staff for planned installations, support and training of all versions of QualOptima. The QualOptima Versions 1 is the Practice Evaluation Application with Version 1.3 integrating performance measurement with peer review and previously announced Version 1.5 proctoring for evaluation of current clinical competence. The array of InterSystems strategic technology platform is leveraged adding Version 1.2 Qtriggers to machine read narrative text in medical records for clinical quality improvement and patient safety opportunities for improvement and optimizing revenue while reducing healthcare costs. Version 1.2 will implement iKnow technology with another licensed technology of Q for this natural language processing (NLP) data analytics platform to even further differentiate Q and its QualOptima product in the healthcare market.
Commercial sales and installations of these QualOptima versions have required expanding Q management, staff and infrastructure. Q's market analysis includes compliance requirements, clinical quality and patient safety, revenue enhancement, value-driven care and value-based purchasing, and enterprise management through outcomes analytics. The Go to Market Plan focuses on the initial market of Q to healthcare providers and payers to achieve optimal clinical, financial and operational outcomes.
"Q's confidence in its intellectual property and technology to become the market leader from our first mover position in clinical outcomes analytics and solutions has increased exponentially as the needs of healthcare customers evolve," said Landon Feazell, Chairman and CEO of Quture. "Q's Go to Market Plan envisions all potential customer segments, ranging from providers like hospitals, physician groups, HMOs, and Accountable Care Organizations, to payers like health insurers and exchanges and other insurers, especially medical malpractice companies, to pharmaceutical companies and medical device manufacturers, to consultants like healthcare law firms, financial and accounting firms, regulators and government entities."
The QualOptima Analytics & Connectivity System is transformative technology to enhance clinical performance to achieve optimal patient outcomes. As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions.
"Our long-term strategy is to market to additional customer segments to provide the platform and clinical knowledge solutions to empower interchange of information between patients, providers and payers for the changing medical model," said Feazell. "With the power of our technology platform to exchange information through mobile applications, Q is extremely confident in our marketing and technology development strategies for Q's short and long-term future."
About Quture International, Inc.
Quture International (OTCQB: QUTR) is the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare. Q's first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. Q's QualOptima Connectivity & Analytics System empowers value-driven, patient-centered, personalized care focused on real-time and predictive patient management and patient safety, with optimal quality demonstrated by outcomes correlated with resource use, revenue and cost. As an Application Partner of InterSystems Corporation, Q's software operates on their HealthShare strategic technology platform to capture, integrate, aggregate, and analyze data transformed to knowledge in Q's innovative second-generation database. InterSystems (www.intersystems.com) has customers in over 100 countries with 80% of top hospitals in America currently utilizing its technology. Q's core competence and value proposition lies in its embedded evidence-based metrics, clinical content and analytic algorithms developed from over 35 years of measuring performance in hundreds of hospitals, physician organizations and HMO's.
As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions. Q is a Nevada corporation based in Daytona Beach, Florida, and trades on the OTC exchange under the symbol 'QUTR.'
Forward Looking Statements: This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.
Email: [email protected]
SYS-CON Events announced today that Transparent Cloud Computing (T-Cloud) Consortium will exhibit at the 19th International Cloud Expo®, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The Transparent Cloud Computing Consortium (T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data proces...
Oct. 24, 2016 04:30 PM EDT Reads: 1,361
In his session at 19th Cloud Expo, Claude Remillard, Principal Program Manager in Developer Division at Microsoft, will contrast how his team used config as code and immutable patterns for continuous delivery of microservices and apps to the cloud. He will show the immutable patterns helps developers do away with most of the complexity of config as code-enabling scenarios such as rollback, zero downtime upgrades with far greater simplicity. He will also have live demos of building immutable pipe...
Oct. 24, 2016 04:30 PM EDT Reads: 1,570
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, discussed how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.
Oct. 24, 2016 04:15 PM EDT Reads: 2,722
The Internet of Things (IoT), in all its myriad manifestations, has great potential. Much of that potential comes from the evolving data management and analytic (DMA) technologies and processes that allow us to gain insight from all of the IoT data that can be generated and gathered. This potential may never be met as those data sets are tied to specific industry verticals and single markets, with no clear way to use IoT data and sensor analytics to fulfill the hype being given the IoT today.
Oct. 24, 2016 04:15 PM EDT Reads: 2,590
Oct. 24, 2016 04:00 PM EDT Reads: 3,710
Oct. 24, 2016 03:45 PM EDT Reads: 1,398
Oct. 24, 2016 03:45 PM EDT Reads: 2,549
Oct. 24, 2016 02:15 PM EDT Reads: 3,988
Oct. 24, 2016 02:15 PM EDT Reads: 3,932
Oct. 24, 2016 02:00 PM EDT Reads: 34,150
Oct. 24, 2016 01:15 PM EDT Reads: 1,448
Oct. 24, 2016 01:00 PM EDT Reads: 1,006
Oct. 24, 2016 01:00 PM EDT Reads: 847
Oct. 24, 2016 01:00 PM EDT Reads: 872
Oct. 24, 2016 12:45 PM EDT Reads: 4,716